
Cervical Cancer patients join study
Clinical research at Mount Vernon Cancer Centre that could drastically improve the survival chances of women with cervical cancer in the future is well underway.
Medical research boosts survival rates and makes in particular cancer treatment kinder on people diagnosed in the future. See some of our research articles below:
Clinical research at Mount Vernon Cancer Centre that could drastically improve the survival chances of women with cervical cancer in the future is well underway.
With the UK lagging behind many other rich countries in the early diagnosis of cancer, our new partnership with the NHS and family doctors offers a solution.
A gift left to us by a supporter in her Will is helping to fund a new research collaboration with Mount Vernon Cancer Centre.
A consultant radiologist at Paul Strickland Scanner Centre has received an award for “going above and beyond” during Covid-19 by playing a key role in a project to make remote reporting of scans a reality at the centre.
People with cancer are now able to benefit from lower radiation doses than ever before when having CT scans as part of their routine medical care and follow up. Dr Andrew Gogbashian explains.
With a brand new, faster Positron Emission Tomography and Computed Tomography (PET-CT) scanner due for installation at the Centre in 2022, Dr Wai-Lup Wong gives insight into the fascinating history of this revolutionary scanning technique which counts our founder, Dr Paul Strickland, as one of its pioneers.
A unique collaboration between Paul Strickland Scanner Centre (PSSC) and Mount Vernon Cancer Centre (MVCC) is seen as hugely beneficial to the care and treatment of cancer patients at Mount Vernon.
Research made possible by a gift left in her Will by a supporter of PSSC finds that whole-body MRI could drastically improve metastatic breast cancer care.
Collaborative project between Paul Strickland Scanner Centre and Mount Vernon Hospital shows how patients can be spared excess radiation.
We’ve joined a pilot study for the Vague Symptoms Pathway (VSP), a programme that could one day lead to a faster diagnosis of cancer for patients. The programme aims to find the quickest, most efficient way to reach a diagnosis in patients who visit their GP with non-specific symptoms. Although
Results of the PROSTAGRAM trial, held at Imperial College London and Paul Strickland Scanner Centre, have just been published in the prestigious medical journal, JAMA Oncology.
People being treated for metastatic breast cancer could be granted precious extra healthy time with their loved ones, thanks to the results of a landmark research study supported by Paul Strickland Scanner Centre.
Mount Vernon Hospital
Northwood, Middlesex
HA6 2RN
Registered charity no. 298867
Registered company no. 2033936 (England and Wales)
About us
Support us
Help